Physiotherapy - Research Publications

Permanent URI for this collection

http://hdl.handle.net/11343/260

Filters

2008 - 2009 2
2
Reset filters

Settings
Statistics
Citations
Start date: 2001 × End date: 2009 × Author: MORRIS, MEG × Author: MURPHY, ANNA ×

Search Results

Now showing 1 - 2 of 2
  • Item
    Thumbnail Image
    Quantifying the profile and progression of impairments, activity, participation, and quality of life in people with Parkinson disease: protocol for a prospective cohort study.
    Morris, ME ; Watts, JJ ; Iansek, R ; Jolley, D ; Campbell, D ; Murphy, AT ; Martin, CL (Springer Science and Business Media LLC, 2009-01-20)
    BACKGROUND: Despite the finding that Parkinson disease (PD) occurs in more than one in every 1000 people older than 60 years, there have been few attempts to quantify how deficits in impairments, activity, participation, and quality of life progress in this debilitating condition. It is unclear which tools are most appropriate for measuring change over time in PD. METHODS AND DESIGN: This protocol describes a prospective analysis of changes in impairments, activity, participation, and quality of life over a 12 month period together with an economic analysis of costs associated with PD. One-hundred participants will be included, provided they have idiopathic PD rated I-IV on the modified Hoehn & Yahr (1967) scale and fulfil the inclusion criteria. The study aims to determine which clinical and economic measures best quantify the natural history and progression of PD in a sample of people receiving services from the Victorian Comprehensive Parkinson's Program, Australia. When the data become available, the results will be expressed as baseline scores and changes over 3 months and 12 months for impairment, activity, participation, and quality of life together with a cost analysis. DISCUSSION: This study has the potential to identify baseline characteristics of PD for different Hoehn & Yahr stages, to determine the influence of disease duration on performance, and to calculate the costs associated with idiopathic PD. Valid clinical and economic measures for quantifying the natural history and progression of PD will also be identified. TRIAL REGISTRATION: ACTRN12609000008224.
  • Item
    Thumbnail Image
    Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial.
    Watts, JJ ; McGinley, JL ; Huxham, F ; Menz, HB ; Iansek, R ; Murphy, AT ; Waller, ER ; Morris, ME (Springer Science and Business Media LLC, 2008-09-30)
    BACKGROUND: Cost of illness studies show that Parkinson disease (PD) is costly for individuals, the healthcare system and society. The costs of PD include both direct and indirect costs associated with falls and related injuries. METHODS: This protocol describes a prospective economic analysis conducted alongside a randomised controlled trial (RCT). It evaluates whether physical therapy is more cost effective than usual care from the perspective of the health care system. Cost effectiveness will be evaluated using a three-way comparison of the cost per fall averted and the cost per quality adjusted life year saved across two physical therapy interventions and a control group. CONCLUSION: This study has the potential to determine whether targetted physical therapy as an adjunct to standard care can be cost effective in reducing falls in people with PD. TRIAL REGISTRATION: No: ACTRN12606000344594.